David Lum

8PUBLICATIONS
124CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 26, 2026
BRD9 Degraders Unleash GBAF Chromatin Remodeling Activity in Synovial Sarcoma.

|Apr 22, 2026
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.

|Jul 01, 2024
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.

Eric A Smith, Rachel L Belote, Nelly M Cruz

|Jun 18, 2024
Zinc-alpha-2-glycoprotein Secreted by Triple-Negative Breast Cancer Promotes Peritumoral Fibrosis.

Surbhi Verma, Stephanie D Giagnocavo, Meghan C Curtin

|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

|Nov 06, 2023
Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression.

Gennie L Parkman, Tursun Turapov, David A Kircher

Pageof 2

Frequent Collaborators

2 joint publications

Kevin B Jones

2 joint publications

Jeffrey H Chuang

2 joint publications

Bryan E Welm

2 joint publications

Alana L Welm